Insights on Patient-Focused Drug Development (PFDD) OUR INSIGHTS LEARN MORE Contact Us We share our insights to keep you updated on patient engagement initiatives, trends, and regulatory guidelines Down arrow icon

OUR INSIGHTS

Limitations of Patient Reported Outcome Measures (PROMs)
Laura Lassen
Posted by Laura Lassen
October 2, 2020

Why PROMs do not guarantee a full picture of patients’ experiences with new drugs

The limitations of Patient Reported Outcome Measures (PROMs). Traditional PROMs (consisting of closed-end questions) have for many years been applied to reveal the patients’ experiences of effects…

Read More
Hearing patients' experiences in clinical trials
Laura Lassen
Posted by Laura Lassen
September 25, 2020

Can you afford to launch a new drug without hearing what patients think about it?

Get the full picture of a treatment. To ensure that you get a clearer picture of a treatment, we recommend interviewing the users who are exposed to a drug candidate as early as possible in the trial…

Read More
Clinigma Patient Interview Portal
Laura Lassen
Posted by Laura Lassen
September 4, 2020

Introducing the Clinigma® Portal

An IT portal facilitating secure and easy collection of trial patient feedback. Patient insights and experiences are critical for pharmaceutical companies to successfully bring new drugs to market…

Read More
The new Clinigma website
Laura Lassen
Posted by Laura Lassen
August 31, 2020

Our new website is live!

Visit the new Clinigma® website today. We are very excited to announce that our new and refreshed website www.clinigma.com is now live. The updated site includes all the information you need to learn more…

Read More
Listen to the patients in your clinical trials
Laura Lassen
Posted by Laura Lassen
August 19, 2020

The importance of listening to the patients in clinical trials

Increasing use of qualitative research methods in clinical trials. At Clinigma®, we are not the only ones recognizing the value of listening to the patients in clinical trials. Increasingly, regulatory agencies…

Read More
Listen to the patients in your clinical trials with Clinigma
Laura Lassen
Posted by Laura Lassen
July 31, 2020

Clinical Survey Outcomes changes name to Clinigma®

We are changing our name - but not our purpose. Clinigma® specializes in designing, interviewing and analyzing patient feedback on investigational drugs in clinical trials as advised by regulatory guidelines…

Read More